tiprankstipranks
10X Genomics (TXG)
NASDAQ:TXG
US Market
TXG
10x Genomics
RESEARCH TOOLSreports
Want to see TXG full AI Analyst Report?

10x Genomics (TXG) Income Statement

1,238 Followers

10x Genomics Income Statement

Last quarter (Q1 2026), 10x Genomics's total revenue was $150.84M, a decrease of -2.61% from the same quarter last year. In Q1, 10x Genomics's net income was $-13.47M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 642.82M$ 610.78M$ 618.73M$ 516.41M$ 490.49M
Gross Profit
$ 443.88M$ 414.48M$ 409.31M$ 396.02M$ 416.40M
Operating Expenses
$ 554.77M$ 609.04M$ 674.64M$ 563.97M$ 469.31M
Depreciation and Amortization
$ 0.00$ 43.71M$ 43.62M$ 33.01M$ 28.25M
EBITDA
$ -110.89M$ -133.99M$ -205.11M$ -128.49M$ -24.59M
Operating Income
$ -110.89M$ -194.56M$ -265.33M$ -167.94M$ -52.91M
Other Income/Expenses
$ 70.98M$ 16.86M$ 16.57M$ 5.97M$ -802.00K
Pretax Income
$ -39.91M$ -177.70M$ -248.76M$ -161.97M$ -53.72M
Net Income
$ -43.54M$ -182.63M$ -255.10M$ -166.00M$ -58.22M
Per Share Metrics
Basic EPS
$ -0.35$ -1.52$ -2.18$ -1.46$ -0.53
Diluted EPS
$ -0.35$ -1.52$ -2.18$ -1.46$ -0.53
Weighted Average Shares Outstanding
 124.75M 120.45M 117.17M 113.86M 110.35M
Weighted Average Shares Outstanding (Diluted)
 124.75M 120.45M 117.17M 113.86M 110.35M
Currency in USD

10x Genomics Earnings and Revenue History